Leiv Ose
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 33
- Surgery top 0.5%
- Lipoproteins and Cardiovascular Health 98
- Cholesterol and Lipid Metabolism 17
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism 40
-
- Lipid metabolism and disorders 13
- Biochemistry top 2%
-
- Atherosclerosis and Cardiovascular Diseases 13
-
- Pharmaceutical Economics and Policy 13
-
- Folate and B Vitamins Research 13
- Co-authors
- Trond P. LerenKjetil RetterstølSerena TonstadMarit S. NenseterKirsten B. HolvenKnut Erik BergeBente HalvorsenArne Svilaas
- Journals
- Atherosclerosis (13 papers)Scandinavian Journal of Clinical and Laboratory Investigation (9 papers)Arteriosclerosis Thrombosis and Vascular Biology (7 papers)
- Partner nations
- NorwayUnited StatesNetherlands
In The Last Decade
Leiv Ose
159 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 131
- Endocrinology, Diabetes and Metabolism 1.6k
- Surgery 3.6k
- Cancer Research 1.0k
- Cardiology and Cardiovascular Medicine 910
- Biochemistry 205
Countries citing papers authored by Leiv Ose
This map shows the geographic impact of Leiv Ose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leiv Ose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leiv Ose more than expected).
Fields of papers citing papers by Leiv Ose
This network shows the impact of papers produced by Leiv Ose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leiv Ose. The network helps show where Leiv Ose may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leiv Ose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 14 | |
| 2 | 2013 | 20 | |
| 3 | 2011 | 3 | |
| 4 | 2008 | 26 | |
| 5 | 2008 | 19 | |
| 6 | 2007 | 6 | |
| 7 | 2007 | 22 | |
| 8 | 2006 | 90 | |
| 9 | Hvilke kolesterolsenkende legemidler bør brukes for primærforebygging av hjerte- og karsykdommer? | 2002 | 2 |
| 10 | Retningslinjer for medikamentell primærforebygging av hjerte- og karsykdommer - hvem bør behandles? | 2002 | 3 |
| 11 | Application of simple lipid treatment goals in patients with atherosclerotic disease. | 2000 | 1 |
| 12 | 2000 | 15 | |
| 13 | 2000 | 26 | |
| 14 | 1997 | 8 | |
| 15 | 1996 | 15 | |
| 16 | 1996 | 6 | |
| 17 | 1995 | 19 | |
| 18 | 1993 | 36 | |
| 19 | 1991 | 41 | |
| 20 | 1977 | 49 |
About Leiv Ose
Leiv Ose is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Surgery, having authored 161 papers that have together received 5.8k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (98 papers), Cancer, Lipids, and Metabolism (40 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (33 papers), Cholesterol and Lipid Metabolism (17 papers), Atherosclerosis and Cardiovascular Diseases (13 papers), Pharmaceutical Economics and Policy (13 papers), Folate and B Vitamins Research (13 papers) and Lipid metabolism and disorders (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Surgery (3.6k citations) and Cancer Research (1.0k citations). Leiv Ose has collaborated with scholars based in Norway, United States and Netherlands. Frequent co-authors include Trond P. Leren, Kjetil Retterstøl, Serena Tonstad, Marit S. Nenseter, Kirsten B. Holven, Knut Erik Berge, Bente Halvorsen, Arne Svilaas, Brian W. McCrindle and Trond Berg. Their work appears in journals such as Atherosclerosis, Scandinavian Journal of Clinical and Laboratory Investigation, Arteriosclerosis Thrombosis and Vascular Biology, The American Journal of Cardiology and Journal of Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.